Mirum Pharmaceuticals, Inc. MIRM EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s EBITDA margin?
- Mirum Pharmaceuticals, Inc. (MIRM) reported EBITDA margin of -135.4% in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s EBITDA margin changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s EBITDA margin decreased by 881.9% year-over-year, from -13.8% to -135.4%.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s EBITDA margin?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s EBITDA margin has grown at a -85.5% compound annual growth rate (CAGR), from -903% to 0.4%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.